Literature DB >> 21749327

Inhibition of the chlorinating activity of myeloperoxidase by tempol: revisiting the kinetics and mechanisms.

Raphael F Queiroz1, Sandra M Vaz, Ohara Augusto.   

Abstract

The nitroxide tempol (4-hydroxy-2,2,6,6-tetramethyl piperidine-1-oxyl) reduces tissue injury in animal models of inflammation by mechanisms that are not completely understood. MPO (myeloperoxidase), which plays a fundamental role in oxidant production by neutrophils, is an important target for anti-inflammatory action. By amplifying the oxidative potential of H2O2, MPO produces hypochlorous acid and radicals through the oxidizing intermediates MPO-I [MPO-porphyrin•+-Fe(IV)=O] and MPO-II [MPO-porphyrin-Fe(IV)=O]. Previously, we reported that tempol reacts with MPO-I and MPO-II with second-order rate constants similar to those of tyrosine. However, we noticed that tempol inhibits the chlorinating activity of MPO, in contrast with tyrosine. Thus we studied the inhibition of MPO-mediated taurine chlorination by tempol at pH 7.4 and re-determined the kinetic constants of the reactions of tempol with MPO-I (k=3.5×105 M-1·s-1) and MPO-II, the kinetics of which indicated a binding interaction (K=2.0×10-5 M; k=3.6×10-2 s-1). Also, we showed that tempol reacts extremely slowly with hypochlorous acid (k=0.29 and 0.054 M-1·s-1 at pH 5.4 and 7.4 respectively). The results demonstrated that tempol acts mostly as a reversible inhibitor of MPO by trapping it as MPO-II and the MPO-II-tempol complex, which are not within the chlorinating cycle. After turnover, a minor fraction of MPO is irreversibly inactivated, probably due to its reaction with the oxammonium cation resulting from tempol oxidation. Kinetic modelling indicated that taurine reacts with enzyme-bound hypochlorous acid. Our investigation complements a comprehensive study reported while the present study was underway

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21749327     DOI: 10.1042/BJ20110555

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  7 in total

1.  The nitroxide radical TEMPOL prevents obesity, hyperlipidaemia, elevation of inflammatory cytokines, and modulates atherosclerotic plaque composition in apoE-/- mice.

Authors:  Christine H J Kim; James B Mitchell; Christina A Bursill; Anastasia L Sowers; Angela Thetford; John A Cook; David M van Reyk; Michael J Davies
Journal:  Atherosclerosis       Date:  2015-03-16       Impact factor: 5.162

2.  Uric acid and thiocyanate as competing substrates of lactoperoxidase.

Authors:  Antonia Seidel; Heather Parker; Rufus Turner; Nina Dickerhof; Irada S Khalilova; Sigurd M Wilbanks; Anthony J Kettle; Guy N L Jameson
Journal:  J Biol Chem       Date:  2014-06-13       Impact factor: 5.157

3.  Fluorescent probes for monitoring myeloperoxidase-derived hypochlorous acid: a comparative study.

Authors:  Karolina Pierzchała; Marlena Pięta; Monika Rola; Małgorzata Świerczyńska; Angelika Artelska; Karolina Dębowska; Radosław Podsiadły; Jakub Pięta; Jacek Zielonka; Adam Sikora; Andrzej Marcinek; Radosław Michalski
Journal:  Sci Rep       Date:  2022-06-03       Impact factor: 4.996

4.  Potent reversible inhibition of myeloperoxidase by aromatic hydroxamates.

Authors:  Louisa V Forbes; Tove Sjögren; Françoise Auchère; David W Jenkins; Bob Thong; David Laughton; Paul Hemsley; Garry Pairaudeau; Rufus Turner; Håkan Eriksson; John F Unitt; Anthony J Kettle
Journal:  J Biol Chem       Date:  2013-11-05       Impact factor: 5.157

5.  Human indoleamine 2,3-dioxygenase is a catalyst of physiological heme peroxidase reactions: implications for the inhibition of dioxygenase activity by hydrogen peroxide.

Authors:  Mohammed Freewan; Martin D Rees; Tito S Sempértegui Plaza; Elias Glaros; Yean J Lim; Xiao Suo Wang; Amanda W S Yeung; Paul K Witting; Andrew C Terentis; Shane R Thomas
Journal:  J Biol Chem       Date:  2012-12-03       Impact factor: 5.157

6.  Triazolopyrimidines identified as reversible myeloperoxidase inhibitors.

Authors:  Franck Duclos; Lynn M Abell; David G Harden; Kristen Pike; Kimberly Nowak; Gregory A Locke; Gerald J Duke; Xiaoqin Liu; Gayani Fernando; Scott A Shaw; Benjamin P Vokits; Nicholas R Wurtz; Andrew Viet; Meriah N Valente; Sylwia Stachura; Paul Sleph; Javed A Khan; Ji Gao; Ashok R Dongre; Lei Zhao; Ruth R Wexler; David A Gordon; Ellen K Kick
Journal:  Medchemcomm       Date:  2017-10-26       Impact factor: 3.597

7.  Ultraviolet Hyperspectral Interferometric Microscopy.

Authors:  Ashkan Ojaghi; Meredith E Fay; Wilbur A Lam; Francisco E Robles
Journal:  Sci Rep       Date:  2018-07-02       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.